US5166057A
(en)
†
|
1989-08-28 |
1992-11-24 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand rna virus expression-systems
|
US6887699B1
(en)
|
1990-05-22 |
2005-05-03 |
Medimmune Vaccines, Inc. |
Recombinant negative strand RNA virus expression systems and vaccines
|
US20030054505A1
(en)
*
|
1997-09-26 |
2003-03-20 |
Hong Jin |
Recombinant rsv expression systems and vaccines
|
US7465574B2
(en)
|
1994-09-30 |
2008-12-16 |
Medimmune, Llc |
Recombinant RSV virus expression systems and vaccines
|
DK0780475T4
(da)
|
1995-08-09 |
2006-10-23 |
Schweiz Serum & Impfinst |
Fremgangsmåde til fremstilling af infektiöse negativ-streng RNA-virus
|
US7846455B2
(en)
|
1996-07-15 |
2010-12-07 |
The United States Of America As Represented By The Department Of Health And Human Services |
Attenuated chimeric respiratory syncytial virus
|
US7485440B2
(en)
|
1995-09-27 |
2009-02-03 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
|
US6689367B1
(en)
|
1995-09-27 |
2004-02-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
|
KR100754091B1
(ko)
|
1995-10-31 |
2007-08-31 |
가부시끼가이샤 디나벡 겡뀨쇼 |
자율 복제 능력을 갖는 (-)쇄 rna 바이러스 벡터
|
WO1997016539A1
(fr)
*
|
1995-11-01 |
1997-05-09 |
Dnavec Research Inc. |
Virus sendai recombinant
|
US6699476B1
(en)
|
1996-07-15 |
2004-03-02 |
Peter L. Collins |
Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
|
EP0912724B1
(de)
*
|
1996-07-15 |
2009-12-09 |
The Government of The United States of America, as represented by The Department of Health and Human Services |
Herstellung von attenuierten respiratorischen syncytialvirus-impfstoffen aus klonierten nukleotidsequenzen
|
AU4427897A
(en)
*
|
1996-09-27 |
1998-04-17 |
American Cyanamid Company |
3' genomic promoter region and polymerase gene mutations responsible for att enuation in viruses of the order designated mononegavirales
|
BR9809240A
(pt)
|
1997-05-07 |
2000-06-27 |
Cleveland Clinic Foundation |
Clone de hpiv recombinante, processos para preparar vìrus parainfluenza humano recombinante e para introduzir uma mutação especìfica de sìtio dentro do genoma de um vìrus parainfluenza humano, e, célula hospedeira
|
US7951383B2
(en)
|
1997-05-23 |
2011-05-31 |
The United States Of America As Represented By The Department Of Health And Human Services |
Attenuated parainfluenza virus (PIV) vaccines
|
US7632508B2
(en)
|
1997-05-23 |
2009-12-15 |
The United States Of America |
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
|
AU2007203671B2
(en)
*
|
1997-05-23 |
2011-09-01 |
The Government Of The United States Of America As Represented By The Department Of Health And Human Services |
Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences
|
EP0994949B1
(de)
*
|
1997-05-23 |
2011-03-09 |
THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services |
Herstellung attenuierter parainfluenza-virus impfstoffe aus klonierten nukleotidsequenzen
|
US7201907B1
(en)
|
1997-05-23 |
2007-04-10 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines
|
US20030082209A1
(en)
|
2000-07-05 |
2003-05-01 |
Skiadopoulos Mario H. |
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
|
US7314631B1
(en)
|
1997-05-23 |
2008-01-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect against disease caused by PIV and respiratory syncytial virus (RSV)
|
US7250171B1
(en)
|
1997-05-23 |
2007-07-31 |
United States Of America As Represented By The Dept. Of Health & Human Services |
Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprotein
|
US7208161B1
(en)
|
1997-05-23 |
2007-04-24 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences
|
US6410023B1
(en)
|
1997-05-23 |
2002-06-25 |
United States Of America |
Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene
|
US7192593B2
(en)
|
1997-05-23 |
2007-03-20 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens
|
US7081243B1
(en)
|
1997-07-11 |
2006-07-25 |
Yale University |
Rhabdoviruses with reengineered coats
|
ES2287977T3
(es)
*
|
1997-07-11 |
2007-12-16 |
Yale University |
Rabdovirus con cubiertas rediseñadas.
|
US6830748B1
(en)
*
|
1997-09-26 |
2004-12-14 |
Medimmune Vaccines, Inc. |
Recombinant RSV virus expression systems and vaccines
|
DK2316923T3
(en)
|
1998-06-12 |
2018-01-08 |
Icahn School Med Mount Sinai |
Attenuated influenza viruses with altered interferon antagonist activity for use as vaccines and drugs
|
DE69937999T2
(de)
|
1998-06-12 |
2009-01-29 |
Avir Green Hills Biotechnology Research Development Trade Ag |
Interferon induzierende genetisch veränderte attenuierte viren
|
EP0974660A1
(de)
|
1998-06-19 |
2000-01-26 |
Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) |
Newcastle-Krankheitsvirus Infektiöser Klone, Impfstoffe und Diagnosetest
|
US6146642A
(en)
*
|
1998-09-14 |
2000-11-14 |
Mount Sinai School Of Medicine, Of The City University Of New York |
Recombinant new castle disease virus RNA expression systems and vaccines
|
US6544785B1
(en)
|
1998-09-14 |
2003-04-08 |
Mount Sinai School Of Medicine Of New York University |
Helper-free rescue of recombinant negative strand RNA viruses
|
US7691389B2
(en)
|
1998-12-22 |
2010-04-06 |
Pfizer Inc |
Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
|
US7618797B2
(en)
|
1998-12-22 |
2009-11-17 |
Pfizer Inc |
Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
|
IL144084A0
(en)
*
|
1999-02-03 |
2002-05-23 |
Biosante Pharmaceuticals Inc |
Therapeutic calcium phosphate particles and methods of manufacture and use
|
EP1035205A1
(de)
*
|
1999-03-08 |
2000-09-13 |
Stichting Dienst Landbouwkundig Onderzoek |
Sich nicht verbreitendes Pestivirus
|
US8715940B2
(en)
*
|
1999-04-06 |
2014-05-06 |
Wisconsin Alumni Research Foundation |
Method of making recombinant influenza virus
|
CN101260386A
(zh)
|
1999-07-09 |
2008-09-10 |
美国政府健康及人类服务部 |
减毒的人-牛嵌合呼吸道合胞病毒疫苗的生产
|
US7820182B2
(en)
*
|
1999-07-09 |
2010-10-26 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions
|
US8147822B1
(en)
*
|
1999-09-17 |
2012-04-03 |
Wellstat Biologics Corporation |
Oncolytic virus
|
US6764685B1
(en)
|
2000-03-21 |
2004-07-20 |
Medimmune Vaccines, Inc. |
Recombinant parainfluenza virus expression systems and vaccines
|
US6635416B2
(en)
|
2000-04-10 |
2003-10-21 |
Mount Sinai School Of Medicine Of New York University |
Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents
|
CA2322057A1
(en)
*
|
2000-05-18 |
2001-11-18 |
Dnavec Research Inc. |
Paramyxovirus vectors used for transfer of foreign genes
|
JP4791651B2
(ja)
*
|
2000-05-18 |
2011-10-12 |
株式会社ディナベック研究所 |
外来遺伝子導入用パラミクソウイルスベクター
|
CN1455816A
(zh)
*
|
2000-06-23 |
2003-11-12 |
美国氰胺公司 |
从cDNA中挽救犬热病病毒
|
CN1298738C
(zh)
|
2000-06-23 |
2007-02-07 |
惠氏控股有限公司 |
修饰的麻疹病毒v蛋白
|
ATE437223T1
(de)
|
2000-06-23 |
2009-08-15 |
Intervet Int Bv |
Attenuiertes bovines respiratorisches syncytialvirus
|
AU2001290273A1
(en)
*
|
2000-10-06 |
2002-04-22 |
Dnavec Research Inc. |
Paramyxovirus vector for transferring foreign gene into skeletal muscle
|
JP2002142770A
(ja)
*
|
2000-11-08 |
2002-05-21 |
Dnavec Research Inc |
循環系への遺伝子送達用パラミクソウイルスベクター
|
WO2002098457A2
(en)
*
|
2001-01-17 |
2002-12-12 |
Thomas Jefferson University |
Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses
|
US8715922B2
(en)
|
2001-01-19 |
2014-05-06 |
ViroNovative |
Virus causing respiratory tract illness in susceptible mammals
|
US20030232061A1
(en)
*
|
2001-10-18 |
2003-12-18 |
Fouchier Ronaldus Adrianus Maria |
Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
|
SG149684A1
(en)
|
2001-01-19 |
2009-02-27 |
Vironovative Bv |
A virus causing respiratory tract illness in susceptible animals
|
WO2003005964A2
(en)
*
|
2001-07-11 |
2003-01-23 |
University Of Miami |
Recombinant vsv for the treatment of tumor cells
|
JP2005510249A
(ja)
*
|
2001-07-20 |
2005-04-21 |
ザ ユニヴァーシティ オブ ジョージア リサーチファウンデーション, インク. |
狂犬病に対するワクチン接種と中枢神経系における遺伝子治療のためのリン酸化部位において核蛋白質が変異した弱毒化狂犬病ウイルス
|
EP1576090A4
(de)
|
2002-02-21 |
2008-07-16 |
Medimmune Vaccines Inc |
Metapneumovirusstämme und ihre verwendung in impfstofformulierungen und als vektor zur expression antigener sequenzen
|
US7465456B2
(en)
|
2002-04-26 |
2008-12-16 |
Medimmune, Llc |
Multi plasmid system for the production of influenza virus
|
KR101229202B1
(ko)
|
2002-04-26 |
2013-02-01 |
메디뮨 엘엘씨 |
인플루엔자 바이러스의 생산을 위한 다중 플라스미드 시스템
|
FR2839453B1
(fr)
|
2002-05-07 |
2007-05-11 |
Agronomique Inst Nat Rech |
Utilisation de novirhabdovirus modifies pour l'obtention de vaccins
|
US20050260601A1
(en)
*
|
2002-09-09 |
2005-11-24 |
Whitt Michael A |
Recombinant mutants of rhabdovirus and methods of use thereof
|
US7238357B2
(en)
*
|
2002-11-05 |
2007-07-03 |
Allergan, Inc. |
Methods for treating ulcers and gastroesophageal reflux disease
|
US7704720B2
(en)
|
2003-04-25 |
2010-04-27 |
Medimmune, Llc |
Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
|
AU2004249133B2
(en)
|
2003-05-28 |
2009-05-28 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines and gene therapy
|
AU2004250129A1
(en)
*
|
2003-06-09 |
2004-12-29 |
Wyeth |
Improved method for the recovery of non-segmented, negative-stranded RNA viruses from cDNA
|
EP2581093B1
(de)
|
2003-06-16 |
2015-03-18 |
MedImmune, LLC |
Influenza-Hämagglutinin- und Neuraminidase-Varianten
|
EP1697521B1
(de)
*
|
2003-12-23 |
2010-06-02 |
MedImmune, LLC |
Multiplasmid-system zur erzeugung des grippevirus
|
EP2500419B1
(de)
|
2003-12-24 |
2018-03-21 |
De Staat der Nederlanden, vert. door de minister van VWS |
Respiratorischer Synzytial-Virus mit einem in Trans komplementierten Genommangel
|
MX343109B
(es)
|
2004-04-09 |
2016-10-25 |
Wyeth * |
Atenuacion sinergistica del virus de la estomatitis vesicular, vectores de los mismos y composiciones inmunogenicas de los mismos.
|
ES2525672T3
(es)
|
2004-05-25 |
2014-12-29 |
Medimmune, Llc |
Variantes de la hemaglutinina y la neuraminidasa de influenza
|
CA2610632C
(en)
|
2004-06-01 |
2022-10-04 |
Mount Sinai School Of Medicine Of New York University |
Genetically engineered swine influenza virus and uses thereof
|
JP2006121948A
(ja)
*
|
2004-10-27 |
2006-05-18 |
Kyoritsu Seiyaku Kk |
組換えウイルス
|
EP2292246A1
(de)
|
2004-11-12 |
2011-03-09 |
Bayer Schering Pharma Aktiengesellschaft |
Rekombinantes Newcastle Disease Virus
|
JP2008520248A
(ja)
|
2004-11-19 |
2008-06-19 |
ウィスコンシン・アラムナイ・リサーチ・ファウンデイション |
タンデム転写ユニットを有する組換えインフルエンザベクター
|
DE102005006388A1
(de)
|
2005-02-11 |
2006-08-24 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Replikationsdefiziente RNA-Viren als Impfstoffe
|
WO2006088481A2
(en)
|
2005-02-15 |
2006-08-24 |
Mount Sinai School Of Medicine Of New York University |
Genetically engineered equine influenza virus and uses thereof
|
EP1856271A4
(de)
|
2005-03-08 |
2009-11-18 |
Medimmune Vaccines Inc |
Influenza-hämagglutinin- und neuraminidase-varianten
|
US7959929B2
(en)
|
2005-04-21 |
2011-06-14 |
University Of Florida Research Foundation, Inc. |
Materials and methods for respiratory disease control in canines
|
US11865172B2
(en)
|
2005-04-21 |
2024-01-09 |
University Of Florida Research Foundation, Inc. |
Materials and methods for respiratory disease control in canines
|
AU2006262381A1
(en)
|
2005-06-21 |
2007-01-04 |
Medimmune, Llc |
Methods and compositions for expressing negative-sense viral RNA in canine cells
|
US7790434B2
(en)
|
2005-06-21 |
2010-09-07 |
Medimmune, Llc |
Methods and compositions for expressing negative-sense viral RNA in canine cells
|
WO2007047459A1
(en)
|
2005-10-14 |
2007-04-26 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Rabies virus vector systems and compositions and methods thereof
|
GEP20135924B
(en)
|
2005-12-02 |
2013-10-10 |
The Mount Sinai School Of Medicine Of New York Univ |
Chimeric viruses presenting non-native surface proteins and usage thereof
|
CA2647985C
(en)
|
2006-03-31 |
2014-12-30 |
Warf-Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines
|
RU2457250C2
(ru)
|
2006-04-19 |
2012-07-27 |
Медиммуне, Ллк |
Способы и композиции для экспрессии антисмысловой вирусной рнк в клетках собаки
|
SI2007883T1
(sl)
*
|
2006-04-20 |
2012-02-29 |
Wyeth Llc |
Procesi äśiĺ äśenja za osamitev preäśiĺ äśenega virusa vezikularnega stomatitisa iz celiäśne kulture
|
EP2049662A4
(de)
|
2006-07-21 |
2009-12-30 |
Medimmune Llc |
Verfahren und zusammensetzungen zur erhöhung des replikationsvermögens eines influenza-virus
|
JP2010500034A
(ja)
|
2006-08-09 |
2010-01-07 |
メッドイミューン バクシーンズ,インコーポレイティド |
インフルエンザ赤血球凝集素変異体およびノイラミニダーゼ変異体
|
US7785874B2
(en)
*
|
2007-01-11 |
2010-08-31 |
The Salk Institute For Biological Studies |
Compositions and methods for monosynaptic transport
|
ES2523587T3
(es)
|
2007-06-18 |
2014-11-27 |
Medimmune, Llc |
Virus influenza B que tienen alteraciones en el polipéptido hemaglutinina
|
US9474798B2
(en)
|
2007-06-18 |
2016-10-25 |
Wisconsin Alumni Research Foundation |
Influenza M2 protein mutant viruses as live influenza attenuated vaccines
|
US20090186050A1
(en)
*
|
2007-11-16 |
2009-07-23 |
Fouchier Ron A M |
Live attenuated metapneumovirus strains and their use in vaccine formulations and chimeric metapneumovirus strains
|
CN101981182A
(zh)
*
|
2007-12-21 |
2011-02-23 |
惠氏有限责任公司 |
经遗传修饰减毒的疱疹性口炎病毒、其组合物和使用方法
|
EP2085092A1
(de)
|
2008-01-29 |
2009-08-05 |
Bayer Schering Pharma Aktiengesellschaft |
Abgeschwächte onkolytische Paramyxoviren zur Kodierung von Vogel-Zytokinen
|
CA2730408A1
(en)
|
2008-07-11 |
2010-01-14 |
Chin-Fen Yang |
Influenza hemagglutinin and neuraminidase variants
|
WO2010091262A1
(en)
|
2009-02-05 |
2010-08-12 |
Mount Sinai School Of Medicine Of New York University |
Chimeric newcastle disease viruses and uses thereof
|
BRPI1008549A2
(pt)
|
2009-02-12 |
2016-03-15 |
Medimmune Llc |
variantes de neuraminidase e hemaglutinina de influenza
|
CA2787099A1
(en)
|
2009-03-30 |
2010-10-14 |
Anice C. Lowen |
Influenza virus hemagglutinin polypeptides containing stem domains, vaccines and uses thereof
|
US9217157B2
(en)
|
2009-07-27 |
2015-12-22 |
Icahn School Of Medicine At Mount Sinai |
Recombinant influenza viruses and uses thereof
|
US8828406B2
(en)
|
2009-07-30 |
2014-09-09 |
Icahn School Of Medicine At Mount Sinai |
Influenza viruses and uses thereof
|
EP2493912B1
(de)
|
2009-10-26 |
2020-07-29 |
Wisconsin Alumni Research Foundation |
Rekombinante influenzaviren mit hohem titer und erhöhter replikation in vero-zellen
|
US10130697B2
(en)
|
2010-03-23 |
2018-11-20 |
Wisconsin Alumni Research Foundation (Warf) |
Vaccines comprising mutant attenuated influenza viruses
|
AU2011235220B2
(en)
|
2010-03-30 |
2016-03-10 |
Mount Sinai School Of Medicine |
Influenza virus vaccines and uses thereof
|
UA108902C2
(uk)
|
2010-11-10 |
2015-06-25 |
|
Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування
|
JP6087908B2
(ja)
|
2011-06-08 |
2017-03-08 |
ジョシ ヴィシュワスJOSHI Vishwas |
組換えタンパク質および組換えウイルスを作製するための単純な2プラスミド哺乳動物発現系
|
MX2014003308A
(es)
|
2011-09-20 |
2015-03-09 |
Sinai School Medicine |
Vacunas para el virus de la influenza y usos de las mismas.
|
JP6386999B2
(ja)
|
2012-05-17 |
2018-09-05 |
ゾエティス・エルエルシー |
ブタ生殖および呼吸症候群(prrs)ウイルスに対する離乳前の効果的なワクチン接種
|
CN108641002A
(zh)
|
2012-12-18 |
2018-10-12 |
西奈山伊坎医学院 |
流感病毒疫苗及其用途
|
US10232032B2
(en)
|
2013-03-14 |
2019-03-19 |
Emory University |
Recombinant RSV with silent mutations, vaccines, and methods related thereto
|
WO2014159960A1
(en)
|
2013-03-14 |
2014-10-02 |
Icahn School Of Medicine At Mount Sinai |
Antibodies against influenza virus hemagglutinin and uses thereof
|
NZ711946A
(en)
|
2013-03-14 |
2020-05-29 |
Icahn School Med Mount Sinai |
Newcastle disease viruses and uses thereof
|
WO2015009743A1
(en)
|
2013-07-15 |
2015-01-22 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses with enhanced replication in mdck or vero cells or eggs
|
EP3441084A1
(de)
|
2014-02-27 |
2019-02-13 |
Viralytics Limited |
Onkolytisches virus und immunstimulator zur kombinationsbehandlung von krebs
|
US10053671B2
(en)
|
2014-06-20 |
2018-08-21 |
Wisconsin Alumni Research Foundation (Warf) |
Mutations that confer genetic stability to additional genes in influenza viruses
|
US10736956B2
(en)
|
2015-01-23 |
2020-08-11 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus vaccination regimens
|
MX2017010908A
(es)
|
2015-02-26 |
2017-12-07 |
Boehringer Ingelheim Vetmedica Gmbh |
Vacuna bivalente contra el virus de gripe porcina.
|
US10633422B2
(en)
|
2015-06-01 |
2020-04-28 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
|
CN104962580B
(zh)
*
|
2015-06-30 |
2018-04-27 |
浙江大学 |
一种重组植物弹状病毒载体及其构建方法
|
WO2017007839A1
(en)
|
2015-07-06 |
2017-01-12 |
Wisconsin Alumni Research Foundation (Warf) |
Improved influenza virus replication for vaccine development
|
WO2017031401A2
(en)
|
2015-08-20 |
2017-02-23 |
University Of Rochester |
Ns1 truncated virus for the development of canine influenza vaccines
|
WO2017031404A1
(en)
|
2015-08-20 |
2017-02-23 |
University Of Rochester |
Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus
|
US10548966B2
(en)
|
2015-08-20 |
2020-02-04 |
University Of Rochester |
Single-cycle virus for the development of canine influenza vaccines
|
SG11201803581VA
(en)
|
2015-10-29 |
2018-05-30 |
Univ Emory |
Chimeric RSV, Immunogenic Compositions, and Methods of Use
|
JP2019510481A
(ja)
|
2016-02-19 |
2019-04-18 |
ウィスコンシン アルムニ リサーチ ファンデイション |
ワクチン開発のための改善されたb型インフルエンザウイルス複製
|
CA3026256A1
(en)
|
2016-06-03 |
2017-12-07 |
University Of Rochester |
Equine influenza virus live-attenuated vaccines
|
JP7237344B2
(ja)
|
2016-06-15 |
2023-03-13 |
アイカーン スクール オブ メディシン アット マウント サイナイ |
インフルエンザウイルス血球凝集素タンパク質及びその使用
|
BR112019012158A2
(pt)
|
2016-12-14 |
2019-11-12 |
Zoetis Services Llc |
vacinação eficaz contra cepas europeias de vírus da síndrome reprodutiva e respiratória suína (prrs) antes do desmame
|
CA3058652A1
(en)
|
2017-04-07 |
2018-10-11 |
Icahn School Of Medicine At Mount Sinai |
Anti-influenza b virus neuraminidase antibodies and uses thereof
|
JOP20190256A1
(ar)
|
2017-05-12 |
2019-10-28 |
Icahn School Med Mount Sinai |
فيروسات داء نيوكاسل واستخداماتها
|
CA3087239A1
(en)
|
2018-02-27 |
2019-09-06 |
University Of Rochester |
Multivalent live-attenuated influenza vaccine for prevention and control of equine influenza virus (eiv) in horses
|
CN109136200B
(zh)
*
|
2018-09-20 |
2022-02-18 |
中国水产科学研究院黑龙江水产研究所 |
一种重组传染性造血器官坏死病毒及其构建方法与应用
|
US11166996B2
(en)
|
2018-12-12 |
2021-11-09 |
Flagship Pioneering Innovations V, Inc. |
Anellovirus compositions and methods of use
|
US11241492B2
(en)
|
2019-01-23 |
2022-02-08 |
Wisconsin Alumni Research Foundation (Warf) |
Mutations that confer genetic stability to genes in influenza viruses
|
WO2020163804A1
(en)
|
2019-02-08 |
2020-08-13 |
Wisconsin Alumni Research Foundation (Warf) |
Humanized cell line
|
MX2021010343A
(es)
|
2019-02-27 |
2022-01-18 |
Univ Rochester |
Vacuna para la influenza multivalente con virus vivo atenuado para la prevencion y el control del virus de la influenza equina (eiv) en caballos.
|
CN114929269A
(zh)
|
2019-05-01 |
2022-08-19 |
威斯康星校友研究基金会(Warf) |
用于疫苗开发的改进的流感病毒复制
|
US11807872B2
(en)
|
2019-08-27 |
2023-11-07 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant influenza viruses with stabilized HA for replication in eggs
|
CN113234692B
(zh)
*
|
2021-05-11 |
2022-02-22 |
华中农业大学 |
一种包含狂犬病毒糖蛋白的感染性克隆及应用
|
WO2023227758A1
(en)
|
2022-05-25 |
2023-11-30 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Vaccine with reduced anti-vector antigenicity
|
CN114859064B
(zh)
*
|
2022-06-07 |
2023-04-25 |
中国农业科学院兰州兽医研究所 |
一种牛流行热病毒蛋白复合物及在牛流行热病毒自然感染抗体检测中的应用
|